INIFY Laboratories AB
Research INIFY Laboratories AB (INIFY) on Bullrun: market cap NOK 634.10M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINIFY
- ExchangeOL
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyNOK
- Market capNOK 634.10M
- Financial periodQ1 2026
- RevenueSEK 5.98M
- Net income-SEK 21.47M
- Gross margin85.2%
Valuation Snapshot
latest market cap is NOK 634.10M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 22.01M | -SEK 67.89M | n/a | 84.5% | -0.85 | SEK 57.53M | n/a | SEK 106.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-28 | NOK 634.10M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 NOK.
About INIFY Laboratories AB
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
Neovici Holding AB (publ) (IDLDX)
Immunovia publ AB (IMMNOV)
Prostatype Genomics AB (PROGEN)
SenzaGen AB (SENZA)
Spermosens AB (publ) (SPERM.ST)
Vimian Group AB (VIMIAN)
Abera Bioscience AB (ABERA.ST)
Acarix A/S (ACARIX)
Ascelia Pharma AB (publ) (ACE)
AcouSort AB (ACOU)
Active Biotech AB (ACTI)
Aino Health AB (AINO)
Frequently asked questions
What is INIFY Laboratories AB's market cap?
INIFY Laboratories AB's market capitalization is NOK 634.10M.
What does INIFY Laboratories AB do?
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.